Severe Decrease of Growth Velocity in Children With Anorexia Nervosa. Therapeutic Trial of Growth Hormone

Trial Profile

Severe Decrease of Growth Velocity in Children With Anorexia Nervosa. Therapeutic Trial of Growth Hormone

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 07 Mar 2018

At a glance

  • Drugs Somatrogon (Primary)
  • Indications Anorexia nervosa; Growth disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2018 Status changed from recruiting to active, no longer recruiting.
    • 14 Jan 2016 Planned end date changed from 1 Sep 2016 to 1 Mar 2022, as reported by ClinicalTrials.gov.
    • 14 Jan 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Mar 2022, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top